Literature DB >> 25056077

Evaluation of clinical and laboratory findings of pediatric and adult patients with oropharyngeal tularemia in Turkey: a combination of surgical drainage and antibiotic therapy increases treatment success.

Mustafa Gokhan Gozel1, Aynur Engin, Emine Elif Altuntas, İsmail Salk, Ali Kaya, Cem Celik, Ilyas Dokmetas, Mehmet Bakir, Nazif Elaldi.   

Abstract

We analyzed the clinical and laboratory findings of both pediatric and adult patients with oropharyngeal tularemia. We also compared the therapeutic outcomes of patients who underwent surgical drainage of lymph nodes early or late during antibiotic therapy. A total of 68 patients with oropharyngeal tularemia, including 26 children and 42 adults, were enrolled in this study. The average duration between symptom onset and hospital admission was 20.8 days (4-60 days) in the pediatric group and 32.6 days (4-90 days) in the adult group (P = 0.009). The most frequently observed clinical symptoms were sore throat (100% and 100%), fever (96.2% and 90.5%), tonsillitis (69.2% and 78.6%), and rash (15.4% and 11.9%) in the pediatric and adult groups, respectively. However, the frequencies of erythema, tenderness, and fluctuant of enlarged lymph nodes were significantly higher in the adult group than in the pediatric group (P = 0.005, P = 0.029, and P = 0.041, respectively). Treatment failure was observed in 2 (7.7%) pediatric patients and 4 (9.5%) adult patients, for a total of 6 (8.8%) treatment failures in the study group. Similar clinical findings and treatment outcomes were observed in both groups. We concluded that a combination of surgical drainage and antibiotic therapy increases treatment success for patients diagnosed with oropharyngeal tularemia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056077     DOI: 10.7883/yoken.67.295

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  4 in total

1.  Tularemia: A Case Series of Patients Diagnosed at the National Reference Center for Rickettsioses From 2008 to 2017.

Authors:  Anne Darmon-Curti; François Darmon; Sophie Edouard; Aurélie Hennebique; Thomas Guimard; Guillaume Martin-Blondel; Timothée Klopfenstein; Jean-Philippe Talarmin; Didier Raoult; Max Maurin; Pierre-Edouard Fournier
Journal:  Open Forum Infect Dis       Date:  2020-09-19       Impact factor: 3.835

2.  Treatment-failure tularemia in children.

Authors:  Arzu Karlı; Gülnar Şensoy; Şule Paksu; Muhammet Furkan Korkmaz; Ömer Ertuğrul; Rıfat Karlı
Journal:  Korean J Pediatr       Date:  2018-02-28

3.  Pediatric Tularemia-A Case Series From a Single Center in Switzerland.

Authors:  Nina Schöbi; Philipp K A Agyeman; Andrea Duppenthaler; Andreas Bartenstein; Peter M Keller; Franziska Suter-Riniker; Kristina M Schmidt; Matthias V Kopp; Christoph Aebi
Journal:  Open Forum Infect Dis       Date:  2022-06-11       Impact factor: 4.423

Review 4.  Francisella tularensis, Tularemia and Serological Diagnosis.

Authors:  Max Maurin
Journal:  Front Cell Infect Microbiol       Date:  2020-10-26       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.